During the past decade, Respiratory and Meningeal Pathogens Research Unit (RMPRU) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Respiratory and Meningeal Pathogens Research Unit (RMPRU)" are "Group B Streptococcus Infections" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "Respiratory and Meningeal Pathogens Research Unit (RMPRU)" in a lesser frequency.

Most popular intervention types in "Respiratory and Meningeal Pathogens Research Unit (RMPRU)" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Multivalent Group B streptococcus vaccine" (1 trials) and "RSV vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Respiratory and Meningeal Pathogens Research Unit (RMPRU)" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Respiratory and Meningeal Pathogens Research Unit (RMPRU)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Respiratory and Meningeal Pathogens Research Unit (RMPRU), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Respiratory and Meningeal Pathogens Research Unit (RMPRU), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".